Evaluation of the effects of a Polyherbal compound in the treatment of hypertension

Evaluation of herbal formula containing Olea europaea leaf, Hibiscussabdarifa, Matricariachamomilla and Achilleamillefolium in hypertensive patients: a randomised double-blind controlled clinical trial.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016110225772N4

Enrollment

550

Registered

2017-02-10

Start date

2016-11-21

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive. Hypertensive diseases

Interventions

Intervention 1: Intervention group: One capsule is equivalent to 550 grams of vegetable blend 3 times a day (after breakfast, lunch and dinner) for 1 month daily. Intervention 2: Control groups: a pla

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The desire to participate in the study, 2. Men and Women between 25-65 years, 3 patients with mild hypertension, 4-lack of heart disease, 5-lack of kidney disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Diastolic blood pressure. Timepoint: Before intervention,one month after intervention. Method of measurement: questionnaire.;Diastolic blood pressure. Timepoint: Before intervention,one month after intervention. Method of measurement: questionnaire.;LDL. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;HDL. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;Total cholestrol. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;Triglyceride. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.	—

Measure

Time frame

Diastolic blood pressure. Timepoint: Before intervention,one month after intervention. Method of measurement: questionnaire.;Diastolic blood pressure. Timepoint: Before intervention,one month after intervention. Method of measurement: questionnaire.;LDL. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;HDL. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;Total cholestrol. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.;Triglyceride. Timepoint: Before intervention,one month after intervention. Method of measurement: Blood examination.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Abbas Zojaji

Zojaj darman toos Pharmaceutical Company

info@zojaj.club+98 51 3502 4824

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026